Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies

Bedford, Mass., March 29 (Korea Bizwire) — The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax(TM) platform for the production of accessible low-cost and high-quality monoclonal antibodies, benefitting developing countries and patients globally. The high cost of monoclonal antibody (mAb) production makes blockbuster drugs expensive, limiting the markets in which these [...]